BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33657598)

  • 1. Retapamulin Activity Against Pediatric Strains of Mupirocin-resistant Methicillin-resistant Staphylococcus aureus.
    Patel AB; Lighter J; Fulmer Y; Copin R; Ratner AJ; Shopsin B
    Pediatr Infect Dis J; 2021 Jul; 40(7):637-638. PubMed ID: 33657598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and molecular characterization of methicillin-resistant Staphylococcus aureus with mupirocin, fusidic acid and/or retapamulin resistance.
    Chen W; He C; Yang H; Shu W; Cui Z; Tang R; Zhang C; Liu Q
    BMC Microbiol; 2020 Jun; 20(1):183. PubMed ID: 32600253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of retapamulin against linezolid and methicillin-resistant Staphylococcus aureus isolates.
    Candel FJ; Morales G; Picazo JJ
    Rev Esp Quimioter; 2011 Sep; 24(3):127-30. PubMed ID: 21947094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Activity of Retapamulin and Antimicrobial Susceptibility Patterns in a Longitudinal Collection of Methicillin-Resistant Staphylococcus aureus Isolates from a Veterans Affairs Medical Center.
    Harrington AT; Black JA; Clarridge JE
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1298-303. PubMed ID: 26666950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the potential for mutational resistance to XF-73, retapamulin, mupirocin, fusidic acid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus isolates during a 55-passage study.
    Farrell DJ; Robbins M; Rhys-Williams W; Love WG
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1177-81. PubMed ID: 21149626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin.
    Woodford N; Afzal-Shah M; Warner M; Livermore DM
    J Antimicrob Chemother; 2008 Oct; 62(4):766-8. PubMed ID: 18567573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased susceptibilities to Retapamulin, Mupirocin, and Chlorhexidine among Staphylococcus aureus isolates causing skin and soft tissue infections in otherwise healthy children.
    McNeil JC; Hulten KG; Kaplan SL; Mason EO
    Antimicrob Agents Chemother; 2014 May; 58(5):2878-83. PubMed ID: 24614375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of Staphylococcus aureus to topical agents in the United States: a sentinel study.
    Biedenbach DJ; Bouchillon SK; Johnson SA; Hoban DJ; Hackel M
    Clin Ther; 2014 Jun; 36(6):953-60. PubMed ID: 24835558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug-resistant clones of community-associated meticillin-resistant Staphylococcus aureus isolated from Chinese children and the resistance genes to clindamycin and mupirocin.
    Wang L; Liu Y; Yang Y; Huang G; Wang C; Deng L; Zheng Y; Fu Z; Li C; Shang Y; Zhao C; Sun M; Li X; Yu S; Yao K; Shen X
    J Med Microbiol; 2012 Sep; 61(Pt 9):1240-1247. PubMed ID: 22595913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No decrease in susceptibility to NVC-422 in multiple-passage studies with methicillin-resistant Staphylococcus aureus, S. aureus, Pseudomonas aeruginosa, and Escherichia coli.
    D'Lima L; Friedman L; Wang L; Xu P; Anderson M; Debabov D
    Antimicrob Agents Chemother; 2012 May; 56(5):2753-5. PubMed ID: 22354299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Diversity Analysis of Mupirocin-Resistant
    Goudarzi M; Fazeli M; Eslami G; Pouriran R
    Microb Drug Resist; 2019 May; 25(4):558-566. PubMed ID: 30499764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections.
    Fritz SA; Hogan PG; Camins BC; Ainsworth AJ; Patrick C; Martin MS; Krauss MJ; Rodriguez M; Burnham CA
    Antimicrob Agents Chemother; 2013 Jan; 57(1):559-68. PubMed ID: 23147738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice.
    Guo Y; Ramos RI; Cho JS; Donegan NP; Cheung AL; Miller LS
    Antimicrob Agents Chemother; 2013 Feb; 57(2):855-63. PubMed ID: 23208713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to chlorhexidine and mupirocin among methicillin-resistant Staphylococcus aureus clinical isolates from a teaching hospital.
    Bes TM; Perdigão-Neto L; Martins RR; Heijden I; Trindade PA; Camilo G; Nagano DS; Mongelos D; Marchi AP; Tomaz M; Oliveira LM; Rossi F; Levin AS; Costa SF
    Rev Inst Med Trop Sao Paulo; 2021; 63():e27. PubMed ID: 33852710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mupirocin resistance related to increasing mupirocin use in clinical isolates of methicillin-resistant Staphylococcus aureus in a pediatric population.
    Hogue JS; Buttke P; Braun LE; Fairchok MP
    J Clin Microbiol; 2010 Jul; 48(7):2599-600. PubMed ID: 20421433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methicillin-susceptible and -resistant Staphylococcus aureus with high-level antiseptic and low-level mupirocin resistance in Malaysia.
    Ghasemzadeh-Moghaddam H; van Belkum A; Hamat RA; van Wamel W; Neela V
    Microb Drug Resist; 2014 Oct; 20(5):472-7. PubMed ID: 24841796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive in vivo imaging to evaluate immune responses and antimicrobial therapy against Staphylococcus aureus and USA300 MRSA skin infections.
    Cho JS; Zussman J; Donegan NP; Ramos RI; Garcia NC; Uslan DZ; Iwakura Y; Simon SI; Cheung AL; Modlin RL; Kim J; Miller LS
    J Invest Dermatol; 2011 Apr; 131(4):907-15. PubMed ID: 21191403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-genotype strains of methicillin-resistant Staphylococcus aureus with high-level mupirocin resistance in a neonatal intensive care unit.
    Park SH; Kim SY; Lee JH; Park C; Lee DG
    Early Hum Dev; 2013 Sep; 89(9):661-5. PubMed ID: 23707691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of retapamulin against Streptococcus pyogenes and Staphylococcus aureus evaluated by agar dilution, microdilution, E-test, and disk diffusion methodologies.
    Pankuch GA; Lin G; Hoellman DB; Good CE; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2006 May; 50(5):1727-30. PubMed ID: 16641442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasopharyngeal carriage, spa types and antibiotic susceptibility profiles of Staphylococcus aureus from healthy children less than 5 years in Eastern Uganda.
    Kateete DP; Asiimwe BB; Mayanja R; Mujuni B; Bwanga F; Najjuka CF; Källander K; Rutebemberwa E
    BMC Infect Dis; 2019 Dec; 19(1):1023. PubMed ID: 31791276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.